4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ABL Diagnostics Société anonyme (ABLD) operates in the Health Information Services industry and is headquartered in Woippy, France with about 22 employees. Its market capitalization is roughly €39 million. In the fiscal year ended 2025-12-31, ABLD reported €7M in revenue and €1M in net income.
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €7M | €5M | €6M | €9M | — |
| Gross Profit | €7M | €5M | €5M | €8M | — |
| Operating Income (EBIT) | €0M | (€0M) | (€1M) | €0M | — |
| Net Income | €1M | €0M | €0M | €1M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €13M | €12M | €15M | €15M | — |
| Total Liabilities | €5M | €4M | €8M | €9M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABLD viewer.
About TickerBase · Data methodology & sources · Privacy · Terms